120 related articles for article (PubMed ID: 37874076)
21. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with multimorbidity and polypharmacy aimed at improving prescribing practices in primary care: study protocol of a cluster randomized trial.
Del Cura-González I; López-Rodríguez JA; Leiva-Fernández F; Gimeno-Feliu LA; Pico-Soler V; Bujalance-Zafra MJ; Domínguez-Santaella M; Polentinos-Castro E; Poblador-Plou B; Ara-Bardají P; Aza-Pascual-Salcedo M; Rogero-Blanco M; Castillo-Jiménez M; Lozano-Hernández C; Gimeno-Miguel A; González-Rubio F; Medina-García R; González-Hevilla A; Gil-Conesa M; Martín-Fernández J; Valderas JM; Marengoni A; Muth C; Prados-Torres JD; Prados-Torres A;
Trials; 2022 Jun; 23(1):479. PubMed ID: 35681224
[TBL] [Abstract][Full Text] [Related]
23. The association of parity number with multimorbidity and polypharmacy among Iranian women in the Azarcohort: a cross-sectional study.
Faramarzi E; Somi MH; Tutunchi H; Almaspour H; Sanaie S; Asemani S
BMC Womens Health; 2023 Jun; 23(1):295. PubMed ID: 37264361
[TBL] [Abstract][Full Text] [Related]
24. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.
Hanlon P; Nicholl BI; Jani BD; McQueenie R; Lee D; Gallacher KI; Mair FS
BMJ Open; 2018 Jan; 8(1):e018404. PubMed ID: 29332840
[TBL] [Abstract][Full Text] [Related]
25. Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study.
Bodilsen J; Nielsen PB; Søgaard M; Dalager-Pedersen M; Speiser LOZ; Yndigegn T; Nielsen H; Larsen TB; Skjøth F
BMJ; 2021 May; 373():n1135. PubMed ID: 34035000
[TBL] [Abstract][Full Text] [Related]
26. Association of Multimorbidity and Excess Mortality After Fractures Among Danish Adults.
Tran T; Bliuc D; Ho-Le T; Abrahamsen B; van den Bergh JP; Chen W; Eisman JA; Geusens P; Hansen L; Vestergaard P; Nguyen TV; Blank RD; Center JR
JAMA Netw Open; 2022 Oct; 5(10):e2235856. PubMed ID: 36215068
[TBL] [Abstract][Full Text] [Related]
27. Late-life depression and the association with multimorbidity and polypharmacy: a cross-sectional study.
Holvast F; van Hattem BA; Sinnige J; Schellevis F; Taxis K; Burger H; Verhaak PFM
Fam Pract; 2017 Sep; 34(5):539-545. PubMed ID: 28369380
[TBL] [Abstract][Full Text] [Related]
28. Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study.
Hallas J; Margulis AV; Pottegård A; Kristiansen NS; Atsma WJ; Appenteng K; de Vogel S; Kaye JA; Perez-Gutthann S; Arana A
Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):612-619. PubMed ID: 29345103
[TBL] [Abstract][Full Text] [Related]
29. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
30. Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study.
Zhao Y; Wang J; Zhu X; Zhang X; Zhang Y; Zhang W; Dong Y
BMC Geriatr; 2023 Jul; 23(1):423. PubMed ID: 37434147
[TBL] [Abstract][Full Text] [Related]
31. Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications.
Jungo KT; Streit S; Lauffenburger JC
BMC Geriatr; 2021 Mar; 21(1):163. PubMed ID: 33676398
[TBL] [Abstract][Full Text] [Related]
32. Multimorbidity, healthcare utilization and socioeconomic status: A register-based study in Denmark.
Frølich A; Ghith N; Schiøtz M; Jacobsen R; Stockmarr A
PLoS One; 2019; 14(8):e0214183. PubMed ID: 31369580
[TBL] [Abstract][Full Text] [Related]
33. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.
Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C;
BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230
[TBL] [Abstract][Full Text] [Related]
34. Optimising Medications for Patients With Cancer and Multimorbidity: The Case for Deprescribing.
Turner JP; Kantilal K; Kantilal K; Holmes HM; Koczwara B
Clin Oncol (R Coll Radiol); 2020 Sep; 32(9):609-617. PubMed ID: 32563549
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of hyponatremia and increased risk of a subsequent cancer diagnosis: results from a nationwide population-based cohort study.
Holland-Bill L; Christiansen CF; Farkas DK; Donskov F; Jørgensen JOL; Sørensen HT
Acta Oncol; 2018 Apr; 57(4):522-527. PubMed ID: 28920509
[TBL] [Abstract][Full Text] [Related]
36. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden.
Gallacher KI; Batty GD; McLean G; Mercer SW; Guthrie B; May CR; Langhorne P; Mair FS
BMC Med; 2014 Oct; 12():151. PubMed ID: 25280748
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
38. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
[TBL] [Abstract][Full Text] [Related]
39. Multimorbidity and mortality: A 15-year longitudinal registry-based nationwide Danish population study.
Willadsen TG; Siersma V; Nicolaisdóttir DR; Køster-Rasmussen R; Jarbøl DE; Reventlow S; Mercer SW; Olivarius NF
J Comorb; 2018; 8(1):2235042X18804063. PubMed ID: 30364387
[TBL] [Abstract][Full Text] [Related]
40. Multimorbidity as a predictor of health service utilization in primary care: a registry-based study of the Catalan population.
Monterde D; Vela E; Clèries M; Garcia-Eroles L; Roca J; Pérez-Sust P
BMC Fam Pract; 2020 Feb; 21(1):39. PubMed ID: 32066377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
